No abstract available
MeSH terms
-
Aged, 80 and over
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Benzenesulfonates / adverse effects*
-
Benzenesulfonates / therapeutic use
-
Humans
-
Hyperplasia / chemically induced
-
Hyperplasia / diagnosis
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Male
-
Melanoma / drug therapy
-
Melanoma / secondary
-
Niacinamide / analogs & derivatives
-
Nitrosourea Compounds / therapeutic use
-
Organophosphorus Compounds / therapeutic use
-
Phenylurea Compounds
-
Pyridines / adverse effects*
-
Pyridines / therapeutic use
-
Skin / pathology*
-
Skin Diseases / chemically induced*
-
Skin Diseases / diagnosis
-
Skin Neoplasms / pathology
-
Sorafenib
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Nitrosourea Compounds
-
Organophosphorus Compounds
-
Phenylurea Compounds
-
Pyridines
-
Niacinamide
-
Sorafenib
-
fotemustine